Additionally, MT2 is frequently cited in clinical and toxicological reports as an unlicensed tanning agent associated with specific side-effect patterns, making it a relevant compound in safety, pharmacovigilance, and public health-oriented research on off-label or uncontrolled peptide use
References Lee TH, Jawan B, Chou WY, Lu CN, Wu CL, Kuo HM, Concejero AM, Wang CH
Moreover, studies are limited at this time, and the medication hasnt been tested at all on humans during pregnancy
Circulating DPP-4 was analyzed with a sandwich ELISA (R&D systems, Minneapolis, MN, Catalog # AF1180, RRID : AB_354651)
In a Lilly-funded trial comparing Foundayo to Rybelsus, patients with type 2 diabetes on 12 to 36 milligrams of orforglipron lost 15 to 20 pounds on average, while those on 7 to 14 milligrams of Rybelsus lost 8 to 11 pounds